Helicore Biopharma
PrivateLast Round
Series A
Jan 28, 2025
Total Funding Raised
$65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Helicore Biopharma operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in January 2025.
Helicore Biopharma is a biopharmaceutical company developing long-acting antibody-peptide conjugate therapies for the treatment of obesity and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helicore Biopharma Comparables
Compare Helicore Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incregen Therapeutics | 89% | |
| Pep2Tango Therapeutics Inc. | 83% | |
| Verdiva Bio | 80% |
For institutional investors. Book with your work email.
Helicore Biopharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Helicore Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| OrbiMed | Series A |
| Versant Ventures | Series A |
| Wellington Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 67% MoM.
- May 19, 2026
Monthly visitors increased 59% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
Helicore Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Helicore Biopharma's valuation, stock price, and market status.
Is Helicore Biopharma a public or private company?
Helicore Biopharma is a private company.
What is the current stock price of Helicore Biopharma?
Helicore Biopharma is a private company, so its shares have no public market price. Caplight tracks Helicore Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Helicore Biopharma worth (valuation)?
Valuation information for Helicore Biopharma is not publicly available.
Can I buy Helicore Biopharma stock?
Helicore Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Helicore Biopharma's last funding round?
Helicore Biopharma's most recent funding round was Series A on January 28, 2025.
Who are the main investors in Helicore Biopharma?
Key investors in Helicore Biopharma include OrbiMed, Versant Ventures.
Will Helicore Biopharma IPO soon?
No public IPO plans have been announced for Helicore Biopharma.
How can I track Helicore Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Helicore Biopharma's shares on secondary markets.